John Overdeck Two Sigma Investments
John Overdeck is a co-founder of Two Sigma Investments, one of the world’s leading quantitative and technology-driven investment firms. Two Sigma applies data science, machine learning, and large-scale computing to markets across asset classes. Overdeck’s firm is a central reference point in discussions of modern systematic investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Cisco
CSCO
|
+$226M |
| 2 |
JPMorgan Chase
JPM
|
+$212M |
| 3 |
TSMC
TSM
|
+$204M |
| 4 |
Occidental Petroleum
OXY
|
+$194M |
| 5 |
Apple
AAPL
|
+$180M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$271M |
| 2 |
Microsoft
MSFT
|
+$267M |
| 3 |
Canadian Pacific Kansas City
CP
|
+$255M |
| 4 |
Thermo Fisher Scientific
TMO
|
+$226M |
| 5 |
Coca-Cola
KO
|
+$225M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.48% |
| 2 | Healthcare | 15.21% |
| 3 | Industrials | 10.23% |
| 4 | Consumer Discretionary | 10.15% |
| 5 | Financials | 9.15% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1801
Mueller Industries
MLI
$13.6B
| $765K | ﹤0.01% |
+56,488
| New | +$800K |
|
1802
Myers Industries
MYE
$1.23B
| $763K | ﹤0.01% |
+35,333
| New | +$645K |
|
|
BNFT
1803
DELISTED
Benefitfocus, Inc.
BNFT
| $761K | ﹤0.01% |
60,315
-89,312
| -60% | -$953K |
|
1804
Waterstone Financial
WSBF
$378M
| $760K | ﹤0.01% |
39,322
+9,575
| +32% | +$193K |
|
|
AUD
1805
DELISTED
Audacy, Inc.
AUD
| $758K | ﹤0.01% |
262,422
-76,337
| -23% | -$202K |
|
|
SUNS
1806
DELISTED
SLR Senior Investment Corp. Common Stock
SUNS
| $757K | ﹤0.01% |
53,471
-32,363
| -38% | -$452K |
|
|
VBTX
1807
DELISTED
Veritex Holdings
VBTX
| $756K | ﹤0.01% |
19,798
+4,207
| +27% | +$169K |
|
1808
Sea Limited
SE
$75.4B
| $755K | ﹤0.01% |
6,300
-28,443
| -82% | -$4.01M |
|
1809
Goosehead Insurance
GSHD
$2.57B
| $754K | ﹤0.01% |
+9,600
| New | +$852K |
|
|
DFTX
1810
Definium Therapeutics
DFTX
$6.02B
| $752K | ﹤0.01% |
45,185
-29,733
| -40% | -$516K |
|
1811
OFS Capital
OFS
$48.9M
| $752K | ﹤0.01% |
+57,867
| New | +$622K |
|
1812
German American Bancorp
GABC
$1.87B
| $750K | ﹤0.01% |
19,750
-1,732
| -8% | -$69K |
|
1813
Pinnacle Financial Partners Inc
PNFP
$15.2B
| $750K | ﹤0.01% |
+8,144
| New | +$805K |
|
1814
Arbor Realty Trust
ABR
$961M
| $745K | ﹤0.01% |
43,689
-170,238
| -80% | -$2.99M |
|
1815
Transcat
TRNS
$825M
| $744K | ﹤0.01% |
9,164
+348
| +4% | +$28.3K |
|
1816
S&T Bancorp
STBA
$1.76B
| $743K | ﹤0.01% |
25,117
+4,321
| +21% | +$136K |
|
1817
1st Source
SRCE
$2.07B
| $740K | ﹤0.01% |
15,999
+4,449
| +39% | +$220K |
|
1818
Stewart Information Services
STC
$2.12B
| $739K | ﹤0.01% |
12,186
+9,310
| +324% | +$647K |
|
1819
Playboy Inc
PLBY
$147M
| $737K | ﹤0.01% |
+56,312
| New | +$948K |
|
1820
Voyager Therapeutics
VYGR
$214M
| $735K | ﹤0.01% |
+96,457
| New | +$430K |
|
1821
Shattuck Labs
STTK
$809M
| $733K | ﹤0.01% |
172,109
+28,564
| +20% | +$162K |
|
|
SCWX
1822
DELISTED
SecureWorks Corp Class A Common Stock
SCWX
| $733K | ﹤0.01% |
+55,308
| New | +$790K |
|
1823
CRA International
CRAI
$1.08B
| $732K | ﹤0.01% |
8,683
+5,280
| +155% | +$462K |
|
|
EPIX
1824
DELISTED
ESSA Pharma
EPIX
| $732K | ﹤0.01% |
118,440
+100,640
| +565% | +$885K |
|
1825
Constellation Energy
CEG
$98.6B
| $731K | ﹤0.01% |
+13,000
| New | +$634K |
|
Similar funds
John Overdeck's Q1 2022 Portfolio in Review
As of Q1 2022, John Overdeck held 4,846 positions worth $33.9B, down 28% from $46.8B the previous quarter. Its ten largest holdings account for 7.2% of the portfolio.
John Overdeck withdrew a net $11.3B in Q1 2022, closing 2,304 positions and reducing 976 holdings. Its most notable exit was Pfizer, an estimated $271M position sold in full.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Healthcare and Industrials.
Against the trend, John Overdeck opened a new position in Cisco worth $223M.
- John Overdeck's largest Q1 2022 buy was Cisco: 4,001,362 shares worth $223M.
- John Overdeck added most to JPMorgan Chase in Q1 2022, an estimated $212M increase.
- John Overdeck's biggest Q1 2022 reduction was Coca-Cola, cutting an estimated $225M.
- John Overdeck fully exited Pfizer in Q1 2022, selling an estimated $271M.
- John Overdeck's ten largest holdings make up 7.2% of its $33.9B portfolio in Q1 2022.
- John Overdeck opened 656 new positions and closed 2,304 in Q1 2022.
- John Overdeck's portfolio value fell 28% quarter-over-quarter to $33.9B.
Based on Two Sigma Investments's 13F filing for Q1 2022, filed 16 May 2022.